GlaxoSmithKline
GSK
#209
Rank
$81.27 B
Marketcap
$39.86
Share price
2.02%
Change (1 day)
11.12%
Change (1 year)

Earnings for GlaxoSmithKline (GSK)

Earnings in 2024 (TTM): $6.88 B

According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $6.88 B. In 2023 the company made an earning of $7.53 B an increase over its 2022 earnings that were of $6.93 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for GlaxoSmithKline from 2001 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $6.88 B-8.63%
2023 $7.53 B8.58%
2022 $6.93 B13.36%
2021 $6.12 B-30.36%
2020 $8.79 B10.81%
2019 $7.93 B25.28%
2018 $6.33 B37.91%
2017 $4.59 B80.02%
2016 $2.55 B-83.68%
2015 $15.63 B219.06%
2014 $4.89 B-53.64%
2013 $10.56 B-0.27%
2012 $10.59 B-13.03%
2011 $12.18 B149.01%
2010 $4.89 B-60.81%
2009 $12.48 B2.43%
2008 $12.19 B-19.37%
2007 $15.12 B4.68%
2006 $14.44 B19.81%
2005 $12.05 B5.67%
2004 $11.40 B11.61%
2003 $10.22 B43.74%
2002 $7.11 B-9.52%
2001 $7.85 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$9.08 B 31.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.89 B-87.07%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.11 B-25.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.89 B 58.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$7.26 B 5.46%๐Ÿ‡ซ๐Ÿ‡ท France
$0.18 B-97.30%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$14.6 M-99.79%๐Ÿ‡บ๐Ÿ‡ธ USA